fbpx
Connect with us
  • Elysium

Interviews

IRLAB: Developing drug candidates with ‘blockbuster potential’ in Parkinson’s

Parkinson’s is the most common primary neurodegenerative disease after Alzheimer’s, affecting nearly nine million people around the world. This figure...